TARA stock

Protara Therapeutics Inc (TARA) financials · $228.8M cap

Protara Therapeutics Inc (TARA) $228.8M cap.

Cached annual income statement
LineFY2025FY2024
Revenue$0$0
Cost of Revenue$0$0
Gross Profit$0$0
Operating Income-$64.5M-$49.2M
Net Income-$57.4M-$44.6M
EPS (Diluted)$-1.34$-2.17
Cached annual balance sheet
LineFY2025FY2024
Total Assets$209.5M$181.5M
Current Assets$159.5M$172.2M
Cash & Equivalents$49.7M$162.8M
Inventory$0$0
PP&E$759.0K$1.0M
Total Liabilities$13.1M$14.3M
Current Liabilities$10.9M$11.0M
Short-term Debt$0$0
Long-term Debt$0$0
Total Debt$0$0
Shareholders' Equity$196.4M$167.1M
Retained Earnings-$302.4M-$245.0M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$56.4M-$35.8M
CapEx$94.0K$63.0K
Investing Cash Flow-$139.5M$19.2M
Financing Cash Flow$82.7M$139.9M
Dividends Paid$0$0
Net Change in Cash$0$0
Free Cash Flow-$56.5M-$35.9M

FAQ

What is TARA P/E and revenue?

Protara Therapeutics Inc (TARA) $228.8M cap.

What is TARA revenue?

Protara Therapeutics Inc last cached revenue is $0 (FY2025).

Is TARA profitable?

Protara Therapeutics Inc last cached net income is -$57.4M.

What are TARA total assets?

Protara Therapeutics Inc last cached total assets are $209.5M.

What is TARA free cash flow?

Protara Therapeutics Inc last cached free cash flow is -$56.5M.

Not investment advice. Cached statements, not a live tape.